Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation
Тип публикации: Journal Article
Дата публикации: 2002-03-13
scimago Q1
wos Q1
БС1
SJR: 1.801
CiteScore: 11.5
Impact factor: 6.8
ISSN: 00222623, 15204804
PubMed ID:
11931625
Drug Discovery
Molecular Medicine
Краткое описание
The synthesis and structure-activity relationship study of a series of compounds with heterocycles in place of the cis double bond in combretastatin A-4 (CA-4) are described. Substituted tosylmethyl isocyanides were found to be the key intermediates in construction of the heterocycles. Cytotoxicities of the heterocycle-based CA-4 analogues were evaluated against NCI-H460 and HCT-15 cancer cell lines. 3-Amino-4-methoxyphenyl and N-methyl-indol-5-yl were the best replacements for the 3-hydroxy-4-methoxyphenyl in CA-4. 4,5-Disubstituted imidazole was found to be the best for the replacement of the cis double bond in CA-4. Medicinal chemistry efforts led to the discovery of compounds 24h and 25f that were found to be 32 and 82% bioavailable, respectively, in rat. Evaluation of 24h and 25f against murine M5076 reticulum sarcoma in mice revealed that both compounds were orally efficacious with an increase in life span of 38.5 and 40.5%, respectively.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
5
10
15
20
25
|
|
|
Bioorganic and Medicinal Chemistry
21 публикация, 5.6%
|
|
|
European Journal of Medicinal Chemistry
19 публикаций, 5.07%
|
|
|
Journal of Medicinal Chemistry
17 публикаций, 4.53%
|
|
|
Tetrahedron Letters
15 публикаций, 4%
|
|
|
Bioorganic and Medicinal Chemistry Letters
14 публикаций, 3.73%
|
|
|
RSC Advances
11 публикаций, 2.93%
|
|
|
Tetrahedron
10 публикаций, 2.67%
|
|
|
European Journal of Organic Chemistry
8 публикаций, 2.13%
|
|
|
Organic Letters
8 публикаций, 2.13%
|
|
|
Synthetic Communications
8 публикаций, 2.13%
|
|
|
ChemMedChem
7 публикаций, 1.87%
|
|
|
MedChemComm
7 публикаций, 1.87%
|
|
|
Research on Chemical Intermediates
6 публикаций, 1.6%
|
|
|
Journal of Molecular Structure
6 публикаций, 1.6%
|
|
|
Bioorganic Chemistry
6 публикаций, 1.6%
|
|
|
Journal of Organic Chemistry
6 публикаций, 1.6%
|
|
|
Monatshefte fur Chemie
5 публикаций, 1.33%
|
|
|
Journal of Heterocyclic Chemistry
5 публикаций, 1.33%
|
|
|
Organic and Biomolecular Chemistry
5 публикаций, 1.33%
|
|
|
Synthesis
5 публикаций, 1.33%
|
|
|
Chemistry of Heterocyclic Compounds
4 публикации, 1.07%
|
|
|
Scientific Reports
4 публикации, 1.07%
|
|
|
Bulletin of the Korean Chemical Society
4 публикации, 1.07%
|
|
|
Arabian Journal of Chemistry
4 публикации, 1.07%
|
|
|
Advanced Synthesis and Catalysis
4 публикации, 1.07%
|
|
|
Archiv der Pharmazie
4 публикации, 1.07%
|
|
|
New Journal of Chemistry
4 публикации, 1.07%
|
|
|
Acta Crystallographica Section E Structure Reports Online
3 публикации, 0.8%
|
|
|
Molecules
3 публикации, 0.8%
|
|
|
5
10
15
20
25
|
Издатели
|
20
40
60
80
100
120
|
|
|
Elsevier
120 публикаций, 32%
|
|
|
Wiley
53 публикации, 14.13%
|
|
|
Springer Nature
43 публикации, 11.47%
|
|
|
American Chemical Society (ACS)
42 публикации, 11.2%
|
|
|
Royal Society of Chemistry (RSC)
35 публикаций, 9.33%
|
|
|
Taylor & Francis
22 публикации, 5.87%
|
|
|
MDPI
7 публикаций, 1.87%
|
|
|
King Saud University
6 публикаций, 1.6%
|
|
|
Georg Thieme Verlag KG
6 публикаций, 1.6%
|
|
|
International Union of Crystallography (IUCr)
3 публикации, 0.8%
|
|
|
Pleiades Publishing
3 публикации, 0.8%
|
|
|
The Japan Institute of Heterocyclic Chemistry
3 публикации, 0.8%
|
|
|
Bentham Science Publishers Ltd.
2 публикации, 0.53%
|
|
|
SAGE
2 публикации, 0.53%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
2 публикации, 0.53%
|
|
|
Public Library of Science (PLoS)
2 публикации, 0.53%
|
|
|
Scientific Research Publishing
2 публикации, 0.53%
|
|
|
Walter de Gruyter
2 публикации, 0.53%
|
|
|
Oxford University Press
1 публикация, 0.27%
|
|
|
Spandidos Publications
1 публикация, 0.27%
|
|
|
Frontiers Media S.A.
1 публикация, 0.27%
|
|
|
Pharmaceutical Society of Korea
1 публикация, 0.27%
|
|
|
Korean Chemical Society
1 публикация, 0.27%
|
|
|
Sharif University of Technology
1 публикация, 0.27%
|
|
|
Cellule MathDoc/Centre Mersenne
1 публикация, 0.27%
|
|
|
Hindawi Limited
1 публикация, 0.27%
|
|
|
Trans Tech Publications
1 публикация, 0.27%
|
|
|
American Association for Cancer Research (AACR)
1 публикация, 0.27%
|
|
|
World Scientific
1 публикация, 0.27%
|
|
|
20
40
60
80
100
120
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
375
Всего цитирований:
375
Цитирований c 2025:
6
(1.6%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Wang L. et al. Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation // Journal of Medicinal Chemistry. 2002. Vol. 45. No. 8. pp. 1697-1711.
ГОСТ со всеми авторами (до 50)
Скопировать
Wang L., Woods K. W., Li Q., Barr K. J., McCroskey R. W., Hannick S. M., Gherke L., Credo R., Hui Y., Marsh K., Warner R., Lee J. Y., Zielinski Mozng N., Frost D., Rosenberg S. H., Sham H. L. Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation // Journal of Medicinal Chemistry. 2002. Vol. 45. No. 8. pp. 1697-1711.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1021/jm010523x
UR - https://doi.org/10.1021/jm010523x
TI - Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation
T2 - Journal of Medicinal Chemistry
AU - Wang, Le
AU - Woods, Keith W.
AU - Li, Q.
AU - Barr, Kenneth J
AU - McCroskey, Richard W.
AU - Hannick, Steven M
AU - Gherke, Laura
AU - Credo, R.Bruce
AU - Hui, Yu-Hua
AU - Marsh, Kennan
AU - Warner, Robert
AU - Lee, Jang Y.
AU - Zielinski Mozng, Nicolette
AU - Frost, David
AU - Rosenberg, Saul H.
AU - Sham, Hing L.
PY - 2002
DA - 2002/03/13
PB - American Chemical Society (ACS)
SP - 1697-1711
IS - 8
VL - 45
PMID - 11931625
SN - 0022-2623
SN - 1520-4804
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2002_Wang,
author = {Le Wang and Keith W. Woods and Q. Li and Kenneth J Barr and Richard W. McCroskey and Steven M Hannick and Laura Gherke and R.Bruce Credo and Yu-Hua Hui and Kennan Marsh and Robert Warner and Jang Y. Lee and Nicolette Zielinski Mozng and David Frost and Saul H. Rosenberg and Hing L. Sham},
title = {Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation},
journal = {Journal of Medicinal Chemistry},
year = {2002},
volume = {45},
publisher = {American Chemical Society (ACS)},
month = {mar},
url = {https://doi.org/10.1021/jm010523x},
number = {8},
pages = {1697--1711},
doi = {10.1021/jm010523x}
}
Цитировать
MLA
Скопировать
Wang, Le, et al. “Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation.” Journal of Medicinal Chemistry, vol. 45, no. 8, Mar. 2002, pp. 1697-1711. https://doi.org/10.1021/jm010523x.